This inventor holds 1 USPTO granted patent. Top assignee: Kanebo, Limited. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Hisayoshi Tsutsui: Innovator in Pharmaceutical Chemistry
Introduction
Hisayoshi Tsutsui is a notable inventor based in Osaka-fu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. His work focuses on innovative solutions for treating disorders related to myocardial ischemia.
Latest Patents
Hisayoshi Tsutsui holds a patent for a 1,4-benzoxazine derivative and pharmaceutical compositions containing it. The compound is designed to be useful as a medicament for preventing or treating disorders induced by intracellular acidosis during myocardial ischemia. This includes conditions such as cardiac dysfunction, myocardial necrosis, arrhythmia, and reperfusion injury, which are commonly observed in ischemic heart diseases like myocardial infarction and angina pectoris. He has 1 patent to his name.
Career Highlights
Tsutsui is currently associated with Kanebo, Limited, where he continues to contribute to advancements in pharmaceutical research. His work has the potential to impact the treatment of heart diseases significantly, showcasing his dedication to improving patient outcomes.
Collaborations
Hisayoshi Tsutsui has collaborated with notable colleagues, including Manabu Hori and Ikuo Watanabe. These partnerships have likely enhanced the scope and impact of his research efforts.
Conclusion
Hisayoshi Tsutsui is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for innovative treatments for heart-related disorders. His contributions are vital in the ongoing battle against ischemic heart diseases.